Canada ready to discuss COVID-19 vaccine IP waiver, 'not interfering or blocking' -Trudeau

Any such waiver would have to be negotiated through the World Trade Organization (WTO). "We've been working with partners at the WTO to find a consensus-based solution and are ready to discuss proposals, in particular for COVID-19 vaccines," Prime Minister Justin Trudeau told reporters.

Canada is ready to discuss an intellectual property rights (IP) waiver for COVID-19 vaccines and will not block one even though it stresses the importance of protecting patents, officials said on Friday. U.S. President Joe Biden on Wednesday threw his support behind waiving IP rights for COVID-19 vaccines. Any such waiver would have to be negotiated through the World Trade Organization (WTO).

"We've been working with partners at the WTO to find a consensus-based solution and are ready to discuss proposals, in particular for COVID-19 vaccines," Prime Minister Justin Trudeau told reporters. Biden's proposal angered pharmaceutical companies. Firms working on vaccines have reported sharp revenue and profit gains during the crisis.

Canadian International Trade Minister Mary Ng earlier said that Ottawa firmly believed in the importance of protecting IP. "I can assure you Canada is not interfering or blocking. Canada is very much working to find a solution," said Trudeau, who did not give details of the Canadian negotiating stance.

Ng also said Ottawa recognized how much the pharmaceutical industry had done to innovate COVID-19 vaccines, adding that many barriers to access were unrelated to IP, such as supply chain constraints. Canada is still trying to quell a third wave of the coronavirus pandemic that is pushing some healthcare systems to breaking point, particularly in the western province of Alberta.

The U.S. state of Montana will start offering vaccines to around 2,000 Alberta truckers who regularly cross the border, Alberta premier Jason Kenney said on Friday. Truckers will be able to pull over and get vaccinated at a post being set up just south of the border, using surplus Johnson & Johnson vaccines provided by Montana.

The scheme mirrors a similar agreement that the provinces of Saskatchewan and Manitoba have reached with North Dakota. (Additional reporting by Nia Williams in Calgary; Editing by David Goodman/Mark Heinrich and Grant McCool)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)